Conner Mertens 11:10 Well Robert, as you know, we like to talk policy
Semaglutide GLP-1 has shown promising results in weight loss among non-diabetic individuals, indicating its effectiveness extends beyond its initial purpose for managing diabetes
Simultaneously, its GLP-1 receptor agonist activity promotes glucose-dependent insulin release, suppresses inappropriate glucagon secretion, slows gastric emptying, and reduces appetite through central nervous system pathways
Mazard T, Boonsirikamchai P, Overman MJ, Asran MA, Choi H, Herron D, Eng C, Maru DM, Ychou M, Vauthey JN, Loyer EM, Kopetz S
GLP-1 is a peptide hormone generated from proglucagon that is secreted after meals by enteroendocrine L-cells in the distal jejunum, ileum, and colon
Sudhu, who has no connection to Novo Nordisk, plans to switch patients who are obese and have Type 2 diabetes to Wegovy